{"id":18538,"date":"2023-07-04T11:38:01","date_gmt":"2023-07-04T09:38:01","guid":{"rendered":"https:\/\/ggba.swiss\/ebamed-raises-eur-14-35-million-to-propel-its-groundbreaking-cardiac-radiation-ablation-therapy\/"},"modified":"2023-07-13T11:52:43","modified_gmt":"2023-07-13T09:52:43","slug":"ebamed-leve-eur-1435-millions-pour-promouvoir-sa-therapie-revolutionnaire-dablation-par-radiation-cardiaque","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/ebamed-leve-eur-1435-millions-pour-promouvoir-sa-therapie-revolutionnaire-dablation-par-radiation-cardiaque\/","title":{"rendered":"EBAMed l\u00e8ve EUR 14,35 millions pour promouvoir sa th\u00e9rapie r\u00e9volutionnaire d&rsquo;ablation par radiation cardiaque"},"content":{"rendered":"\n<p>Le syst\u00e8me CardioKit d&rsquo;<a href=\"https:\/\/eba-med.com\/\">EBAMed<\/a> a \u00e9t\u00e9 con\u00e7u pour traiter la tachycardie ventriculaire, un trouble cardiaque potentiellement mortel qui touche environ 50 millions de personnes dans le monde. La pr\u00e9valence de cette affection devrait augmenter au cours des cinquante prochaines ann\u00e9es en raison du vieillissement de la population. La technologie d&rsquo;EBAMed permet non seulement d&rsquo;accro\u00eetre la pr\u00e9cision de l&rsquo;administration du faisceau externe, mais aussi d&rsquo;ajuster automatiquement les syst\u00e8mes d&rsquo;ablation par irradiation en fonction des mouvements cardiaques. Cette int\u00e9gration unique de la radioth\u00e9rapie et de la surveillance des mouvements pourrait constituer une avanc\u00e9e significative pour les patients, en offrant une alternative sup\u00e9rieure \u00e0 la pharmacoth\u00e9rapie ou \u00e0 l&rsquo;ablation par cath\u00e9ter.<\/p>\n\n\n\n<p>EBAMed a d\u00e9j\u00e0 re\u00e7u un <a href=\"https:\/\/ggba.swiss\/fr\/le-fongit-innovation-fund-distingue-trois-start-ups-deeptech-genevoises\/\">pr\u00eat de d\u00e9marrage de CHF 100&rsquo;000<\/a> du Fongit Innovation Fund (<a href=\"https:\/\/www.fongit.ch\/fr\/financing\">FIF<\/a>) pour son innovation dans le domaine de la technologie m\u00e9dicale. La derni\u00e8re lev\u00e9e de fonds est men\u00e9e par Panak\u00e8s Partners et comprend le European Innovation Council (EIC) Fund, EFI Lake Geneva Ventures, LIFTT Venture Capital Italia, et OCCIDENT, aux c\u00f4t\u00e9s des investisseurs existants de la soci\u00e9t\u00e9 tels que Mayo Clinic.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">R\u00e9volutionner le traitement des arythmies cardiaques<\/h4>\n\n\n\n<p>Giovanni Leo, cofondateur et pr\u00e9sident d&rsquo;EBAMed, a exprim\u00e9 son enthousiasme quant \u00e0 la r\u00e9ussite du tour de table et a not\u00e9 que la reconnaissance des investisseurs italiens \u00e9tait particuli\u00e8rement gratifiante. En tant qu&rsquo;entreprise italo-suisse, EBAMed est pr\u00eate \u00e0 tirer parti de la diversit\u00e9 de ses talents et de sa filiale r\u00e9cemment ouverte \u00e0 Milan pour \u00e9tendre ses activit\u00e9s en Italie.<\/p>\n\n\n\n<p>Barbara Castellano, partenaire chez Panak\u00e8s Partners, a soulign\u00e9 l&rsquo;importance du travail d&rsquo;EBAMed en raison du probl\u00e8me croissant des arythmies cardiaques \u00e0 l&rsquo;\u00e9chelle mondiale. Les options th\u00e9rapeutiques limit\u00e9es et sous-optimales pour les patients souffrant de tachycardie ventriculaire n\u00e9cessitent des solutions innovantes comme le syst\u00e8me CardioKit d&rsquo;EBAMed. L&rsquo;ablation radio utilisant des protons en conjonction avec le gating respiratoire et cardiaque annonce une nouvelle \u00e8re de m\u00e9decine de pr\u00e9cision, en particulier pour les cas de patients difficiles.<\/p>\n\n\n\n<p>Marina Izzo, CEO d&rsquo;EBAMed, a d\u00e9clar\u00e9 : \u00ab&nbsp;Notre mission est d&rsquo;optimiser la radioth\u00e9rapie pour les indications cardiaques. Avec des d\u00e9veloppements passionnants dans la compensation des mouvements cardio-respiratoires, notre technologie a le potentiel de r\u00e9volutionner le traitement des arythmies cardiaques.&nbsp;\u00bb Elle a ajout\u00e9 que ce nouveau financement permettra d&rsquo;acc\u00e9l\u00e9rer la mise \u00e0 disposition de leur technologie r\u00e9volutionnaire aux patients qui en ont besoin, ce qui pourrait constituer un aspect essentiel des futures m\u00e9thodes d&rsquo;ablation non invasives pour le traitement des arythmies potentiellement mortelles.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La medtech genevoise EBAMed a lev\u00e9 EUR 14,35 millions en s\u00e9rie A. Ce financement permettra d&rsquo;acc\u00e9l\u00e9rer le d\u00e9veloppement du syst\u00e8me CardioKit, le traitement non invasif r\u00e9volutionnaire de l&rsquo;ablation par radiation cardiaque d&rsquo;EBAMed.<\/p>\n","protected":false},"author":6,"featured_media":18535,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[],"class_list":["post-18538","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>EBAMed l\u00e8ve EUR 14,35 millions pour promouvoir sa th\u00e9rapie r\u00e9volutionnaire d&#039;ablation par radiation cardiaque - Greater Geneva Bern area<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/ebamed-leve-eur-1435-millions-pour-promouvoir-sa-therapie-revolutionnaire-dablation-par-radiation-cardiaque\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EBAMed l\u00e8ve EUR 14,35 millions pour promouvoir sa th\u00e9rapie r\u00e9volutionnaire d&#039;ablation par radiation cardiaque - Greater Geneva Bern area\" \/>\n<meta property=\"og:description\" content=\"La medtech genevoise EBAMed a lev\u00e9 EUR 14,35 millions en s\u00e9rie A. Ce financement permettra d&#039;acc\u00e9l\u00e9rer le d\u00e9veloppement du syst\u00e8me CardioKit, le traitement non invasif r\u00e9volutionnaire de l&#039;ablation par radiation cardiaque d&#039;EBAMed.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/ebamed-leve-eur-1435-millions-pour-promouvoir-sa-therapie-revolutionnaire-dablation-par-radiation-cardiaque\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-04T09:38:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-13T09:52:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2023\/07\/EBAmed-630x380-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"630\" \/>\n\t<meta property=\"og:image:height\" content=\"380\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/ebamed-leve-eur-1435-millions-pour-promouvoir-sa-therapie-revolutionnaire-dablation-par-radiation-cardiaque\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/ebamed-leve-eur-1435-millions-pour-promouvoir-sa-therapie-revolutionnaire-dablation-par-radiation-cardiaque\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"EBAMed l\u00e8ve EUR 14,35 millions pour promouvoir sa th\u00e9rapie r\u00e9volutionnaire d&rsquo;ablation par radiation cardiaque\",\"datePublished\":\"2023-07-04T09:38:01+00:00\",\"dateModified\":\"2023-07-13T09:52:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/ebamed-leve-eur-1435-millions-pour-promouvoir-sa-therapie-revolutionnaire-dablation-par-radiation-cardiaque\/\"},\"wordCount\":471,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/ebamed-leve-eur-1435-millions-pour-promouvoir-sa-therapie-revolutionnaire-dablation-par-radiation-cardiaque\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/07\/EBAmed-630x380-1.jpg\",\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/fr\/ebamed-leve-eur-1435-millions-pour-promouvoir-sa-therapie-revolutionnaire-dablation-par-radiation-cardiaque\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/ebamed-leve-eur-1435-millions-pour-promouvoir-sa-therapie-revolutionnaire-dablation-par-radiation-cardiaque\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/ebamed-leve-eur-1435-millions-pour-promouvoir-sa-therapie-revolutionnaire-dablation-par-radiation-cardiaque\/\",\"name\":\"EBAMed l\u00e8ve EUR 14,35 millions pour promouvoir sa th\u00e9rapie r\u00e9volutionnaire d'ablation par radiation cardiaque - Greater Geneva Bern area\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/ebamed-leve-eur-1435-millions-pour-promouvoir-sa-therapie-revolutionnaire-dablation-par-radiation-cardiaque\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/ebamed-leve-eur-1435-millions-pour-promouvoir-sa-therapie-revolutionnaire-dablation-par-radiation-cardiaque\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/07\/EBAmed-630x380-1.jpg\",\"datePublished\":\"2023-07-04T09:38:01+00:00\",\"dateModified\":\"2023-07-13T09:52:43+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/ebamed-leve-eur-1435-millions-pour-promouvoir-sa-therapie-revolutionnaire-dablation-par-radiation-cardiaque\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/ebamed-leve-eur-1435-millions-pour-promouvoir-sa-therapie-revolutionnaire-dablation-par-radiation-cardiaque\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/ebamed-leve-eur-1435-millions-pour-promouvoir-sa-therapie-revolutionnaire-dablation-par-radiation-cardiaque\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/07\/EBAmed-630x380-1.jpg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/07\/EBAmed-630x380-1.jpg\",\"width\":630,\"height\":380,\"caption\":\"La solution d'EBAMed combine des dispositifs m\u00e9dicaux pour la protonth\u00e9rapie, l'imagerie de suivi des mouvements et des logiciels pour permettre le traitement des patients de mani\u00e8re non invasive, en une seule s\u00e9ance ambulatoire, tout en multipliant par 5 le nombre de patients et en r\u00e9duisant les co\u00fbts. | \u00a9 EBAMed\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/ebamed-leve-eur-1435-millions-pour-promouvoir-sa-therapie-revolutionnaire-dablation-par-radiation-cardiaque\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EBAMed l\u00e8ve EUR 14,35 millions pour promouvoir sa th\u00e9rapie r\u00e9volutionnaire d&#8217;ablation par radiation cardiaque\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EBAMed l\u00e8ve EUR 14,35 millions pour promouvoir sa th\u00e9rapie r\u00e9volutionnaire d'ablation par radiation cardiaque - Greater Geneva Bern area","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/ebamed-leve-eur-1435-millions-pour-promouvoir-sa-therapie-revolutionnaire-dablation-par-radiation-cardiaque\/","og_locale":"fr_FR","og_type":"article","og_title":"EBAMed l\u00e8ve EUR 14,35 millions pour promouvoir sa th\u00e9rapie r\u00e9volutionnaire d'ablation par radiation cardiaque - Greater Geneva Bern area","og_description":"La medtech genevoise EBAMed a lev\u00e9 EUR 14,35 millions en s\u00e9rie A. Ce financement permettra d'acc\u00e9l\u00e9rer le d\u00e9veloppement du syst\u00e8me CardioKit, le traitement non invasif r\u00e9volutionnaire de l'ablation par radiation cardiaque d'EBAMed.","og_url":"https:\/\/ggba.swiss\/fr\/ebamed-leve-eur-1435-millions-pour-promouvoir-sa-therapie-revolutionnaire-dablation-par-radiation-cardiaque\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2023-07-04T09:38:01+00:00","article_modified_time":"2023-07-13T09:52:43+00:00","og_image":[{"width":630,"height":380,"url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/07\/EBAmed-630x380-1.jpg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/ebamed-leve-eur-1435-millions-pour-promouvoir-sa-therapie-revolutionnaire-dablation-par-radiation-cardiaque\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/ebamed-leve-eur-1435-millions-pour-promouvoir-sa-therapie-revolutionnaire-dablation-par-radiation-cardiaque\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"EBAMed l\u00e8ve EUR 14,35 millions pour promouvoir sa th\u00e9rapie r\u00e9volutionnaire d&rsquo;ablation par radiation cardiaque","datePublished":"2023-07-04T09:38:01+00:00","dateModified":"2023-07-13T09:52:43+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/ebamed-leve-eur-1435-millions-pour-promouvoir-sa-therapie-revolutionnaire-dablation-par-radiation-cardiaque\/"},"wordCount":471,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/fr\/ebamed-leve-eur-1435-millions-pour-promouvoir-sa-therapie-revolutionnaire-dablation-par-radiation-cardiaque\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/07\/EBAmed-630x380-1.jpg","articleSection":["Sciences de la vie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/fr\/ebamed-leve-eur-1435-millions-pour-promouvoir-sa-therapie-revolutionnaire-dablation-par-radiation-cardiaque\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/ebamed-leve-eur-1435-millions-pour-promouvoir-sa-therapie-revolutionnaire-dablation-par-radiation-cardiaque\/","url":"https:\/\/ggba.swiss\/fr\/ebamed-leve-eur-1435-millions-pour-promouvoir-sa-therapie-revolutionnaire-dablation-par-radiation-cardiaque\/","name":"EBAMed l\u00e8ve EUR 14,35 millions pour promouvoir sa th\u00e9rapie r\u00e9volutionnaire d'ablation par radiation cardiaque - Greater Geneva Bern area","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/ebamed-leve-eur-1435-millions-pour-promouvoir-sa-therapie-revolutionnaire-dablation-par-radiation-cardiaque\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/ebamed-leve-eur-1435-millions-pour-promouvoir-sa-therapie-revolutionnaire-dablation-par-radiation-cardiaque\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/07\/EBAmed-630x380-1.jpg","datePublished":"2023-07-04T09:38:01+00:00","dateModified":"2023-07-13T09:52:43+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/ebamed-leve-eur-1435-millions-pour-promouvoir-sa-therapie-revolutionnaire-dablation-par-radiation-cardiaque\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/ebamed-leve-eur-1435-millions-pour-promouvoir-sa-therapie-revolutionnaire-dablation-par-radiation-cardiaque\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/ebamed-leve-eur-1435-millions-pour-promouvoir-sa-therapie-revolutionnaire-dablation-par-radiation-cardiaque\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/07\/EBAmed-630x380-1.jpg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/07\/EBAmed-630x380-1.jpg","width":630,"height":380,"caption":"La solution d'EBAMed combine des dispositifs m\u00e9dicaux pour la protonth\u00e9rapie, l'imagerie de suivi des mouvements et des logiciels pour permettre le traitement des patients de mani\u00e8re non invasive, en une seule s\u00e9ance ambulatoire, tout en multipliant par 5 le nombre de patients et en r\u00e9duisant les co\u00fbts. | \u00a9 EBAMed"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/ebamed-leve-eur-1435-millions-pour-promouvoir-sa-therapie-revolutionnaire-dablation-par-radiation-cardiaque\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"EBAMed l\u00e8ve EUR 14,35 millions pour promouvoir sa th\u00e9rapie r\u00e9volutionnaire d&#8217;ablation par radiation cardiaque"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/18538","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=18538"}],"version-history":[{"count":2,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/18538\/revisions"}],"predecessor-version":[{"id":18938,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/18538\/revisions\/18938"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/18535"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=18538"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=18538"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=18538"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}